Name: Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies (en Inglés)
Price: 633108.00 COP
Availability: InStock
Author: Pedroza, Abraham; Alvarez-Gomez, Rosa M.
ISBN: 9780443456596

portada Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies (en Inglés)

Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Pedroza, Abraham; Alvarez-Gomez, Rosa M.

Idioma

Inglés

N° páginas

330

Encuadernación

Tapa Blanda

ISBN13

9780443456596

Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies (en Inglés)

Pedroza, Abraham; Alvarez-Gomez, Rosa M. (Autor) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 13 a 19 días háb.

$ 1.266.215$ 633.108

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 20 unidades

$ 633.108

¡Envío Gratis! Llega entre el 14 Ago y el 26 Ago a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies (en Inglés)"

Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies addresses the critical challenge of treatment resistance in oncology. The book provides a comprehensive examination of the cellular, molecular, and genetic mechanisms behind resistance, unveiling insights from cancer biology and genomics that inform novel therapeutic strategies. Sections explore cutting-edge technologies like CAR-T cell therapy, nanotechnology, and artificial intelligence, highlighting their role in discovering new treatment modalities. Readers will find the latest preclinical and clinical data, including newly FDA-approved therapies, demonstrating their potential to improve patient outcomes. For academics, this resource consolidates the latest research and clinical developments, aiding researchers, clinicians, and students in staying updated on advancements. It will also be a great guide for graduate studies and research, offering critical insights into drug development and targeted therapies for professionals in the pharmaceutical and biotechnology sectors, ultimately driving progress in cancer treatment.